Annalora Andrew J, Bobrovnikov-Marjon Ekaterina, Serda Rita, Pastuszyn Andrzej, Graham Sandra E, Marcus Craig B, Omdahl John L
Department of Biochemistry and Molecular Biology, University of New Mexico School of Medicine, Albuquerque, NM 87131-5331, USA.
Arch Biochem Biophys. 2007 Apr 15;460(2):262-73. doi: 10.1016/j.abb.2006.11.018. Epub 2006 Dec 3.
Cytochrome P450C24A1 (CYP24A1), a peripheral inner mitochondrial membrane hemoprotein and candidate oncogene, regulates the side-chain metabolism and biological function of vitamin D and many of its related analog drugs. Rational mutational analysis of rat CYP24A1 based on hybrid (2C5/BM-3) homology modeling and affinity labeling studies clarified the role of key domains (N-terminus, A', A, and F-helices, beta3a strand, and beta5 hairpin) in substrate binding and catalysis. The scope of our study was limited by an inability to purify stable mutant enzyme targeting soluble domains (B', G, and I-helices) and suggested greater conformational flexibility among CYP24A1's membrane-associated domains. The most notable mutants developed by modeling were V391T and I500A, which displayed defective-binding function and profound metabolic defects for 25-hydroxylated vitamin D3 substrates similar to a non-functional F-helix mutant (F249T) that we previously reported. Val-391 (beta3a strand) and Ile-500 (beta5 hairpin) are modeled to interact with Phe-249 (F-helix) in a hydrophobic cluster that directs substrate-binding events through interactions with the vitamin D cis-triene moiety. Prior affinity labeling studies identified an amino-terminal residue (Ser-57) as a putative active-site residue that interacts with the 3beta-OH group of the vitamin D A-ring. Studies with 3-epi and 3-deoxy-1,25(OH)2D3 analogs confirmed interactions between the 3beta-OH group and Ser-57 effect substrate recognition and trafficking while establishing that the trans conformation of A-ring hydroxyl groups (1alpha and 3beta) is obligate for high-affinity binding to rat CYP24A1. Our work suggests that CYP24A1's amphipathic nature allows for monotopic membrane insertion, whereby a pw2d-like substrate access channel is formed to shuttle secosteroid substrate from the membrane to the active-site. We hypothesize that CYP24A1 has evolved a unique amino-terminal membrane-binding motif that contributes to substrate specificity and docking through coordinated interactions with the vitamin D A-ring.
细胞色素P450C24A1(CYP24A1)是一种外周线粒体内膜血红蛋白和候选致癌基因,可调节维生素D及其许多相关类似药物的侧链代谢和生物学功能。基于杂交(2C5/BM - 3)同源性建模和亲和标记研究对大鼠CYP24A1进行的合理突变分析,阐明了关键结构域(N端、A'、A和F螺旋、β3a链和β5发夹)在底物结合和催化中的作用。我们的研究范围受到无法纯化靶向可溶性结构域(B'、G和I螺旋)的稳定突变酶的限制,并表明CYP24A1的膜相关结构域之间具有更大的构象灵活性。通过建模开发的最显著突变体是V391T和I500A,它们表现出结合功能缺陷以及对25 - 羟基化维生素D3底物的严重代谢缺陷,类似于我们之前报道的无功能F螺旋突变体(F249T)。缬氨酸 - 391(β3a链)和异亮氨酸 - 500(β5发夹)在模型中被模拟为与苯丙氨酸 - 249(F螺旋)在一个疏水簇中相互作用,该疏水簇通过与维生素D顺式三烯部分的相互作用来指导底物结合事件。先前的亲和标记研究确定了一个氨基末端残基(丝氨酸 - 57)作为一个假定的活性位点残基,它与维生素D A环的3β - OH基团相互作用。对3 - 表位和3 - 脱氧 - 1,25(OH)2D3类似物的研究证实了3β - OH基团与丝氨酸 - 57之间的相互作用影响底物识别和转运,同时确定A环羟基(1α和3β)的反式构象对于与大鼠CYP24A1的高亲和力结合是必需的。我们的工作表明,CYP24A1的两亲性允许单一位点膜插入,从而形成一个类似pw2d的底物通道,将甾醇类底物从膜穿梭到活性位点。我们假设CYP24A1已经进化出一种独特的氨基末端膜结合基序,通过与维生素D A环的协同相互作用促进底物特异性和对接。